Form 4: AdaptHealth Director Theodore Lundberg Increases Stake Through Equity Awards

AdaptHealth Corp. Director Theodore B. Lundberg reported the acquisition of 29,210 shares of common stock through equity awards, increasing his total beneficial ownership to 859,756 shares.

Summary

• Theodore B. Lundberg, a Director of AdaptHealth Corp. (AHCO), acquired 21,346 shares of common stock on June 26, 2025, at a price of $0 per share.
• Following this transaction, Lundberg's direct beneficial ownership increased to 851,892 shares.
• On the same date, June 26, 2025, Lundberg acquired an additional 7,864 shares of common stock at a price of $0 per share.
• These acquisitions increased his total direct beneficial ownership to 859,756 shares of AdaptHealth Corp. common stock.
• The filing also includes a Power of Attorney granted by Theodore Lundberg to Richard Rew and Shannone Raybon, effective February 19, 2025, authorizing them to prepare and file SEC reports on his behalf.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a director, even if through awards at a $0 price, generally signals continued alignment and confidence in the company's long-term prospects from an insider's perspective.

Positives

• The acquisition of additional shares by a director, even if through awards, indicates continued confidence in the company's future prospects.
• The increase in beneficial ownership aligns the director's interests more closely with those of other shareholders.

Risks

• The Power of Attorney explicitly states that neither AdaptHealth Corp. nor the Attorneys-in-Fact assume any liability for the undersigned's responsibility to comply with Section 13 or Section 16 of the Exchange Act or Rule 144, any liability for any failure to comply with such requirements, or any liability for disgorgement of profits under Section 16(b) of the Exchange Act. This highlights the reporting person's ongoing personal responsibility for compliance with securities regulations.

Future Outlook

Not applicable as this Form 4 filing primarily reports past insider transactions and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transactions. It does not provide information to analyze broader industry trends or the competitive landscape for AdaptHealth Corp. The transactions reflect an individual director's stake rather than a company-wide strategic move or industry-specific development.

Corporate Governance

Related Party Transactions

• The reported acquisitions of common stock by Director Theodore B. Lundberg from AdaptHealth Corp. are considered related-party transactions, as they involve an insider and the company. The shares were acquired at a price of $0, indicating they are likely equity awards or grants as part of compensation.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership may be viewed positively as it aligns management interests with shareholder interests. The issuance of shares for $0 could imply dilution, but this is standard for equity compensation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

Keywords

AdaptHealth Corp., AHCO, Theodore B. Lundberg, Director, Insider Transaction, Form 4, Equity Award, Common Stock, Beneficial Ownership, SEC Filing, Corporate Governance